eXp World (EXPI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
A proposal is presented for redomestication from Delaware to Texas, aiming to align legal frameworks with business realities and enhance shareholder value.
The Board and a special committee of independent directors conducted a formal, year-long review before recommending the move.
Forward-looking statements highlight potential benefits, risks, and uncertainties related to the redomestication, including cost savings, legal implications, and stakeholder responses.
Voting matters and shareholder proposals
Shareholders are asked to approve the redomestication to Texas, with a dual-vote structure requiring majority approval from unaffiliated stockholders.
Affiliated shareholders are excluded from carrying the vote, ensuring the decision reflects the will of independent holders.
Board of directors and corporate governance
The Board evaluated the redomestication for over a year, with a special committee of independent directors conducting a rigorous review.
Texas law offers directors and officers statutory flexibility to consider key constituencies, such as agents, in their fiduciary duties.
The committee found Delaware and Texas corporate laws materially equivalent in governance and litigation rights, with Texas providing greater predictability.
Latest events from eXp World
- Shareholders are asked to approve redomestication to Texas, aligning governance with business needs.EXPI
Proxy filing24 Apr 2026 - Shareholders will vote on redomestication to Texas, with key risks and benefits highlighted.EXPI
Proxy filing23 Apr 2026 - Shareholders will vote on redomestication to Texas, with new litigation thresholds and outlined risks.EXPI
Proxy filing23 Apr 2026 - Stockholders will vote on redomestication to Texas, aiming for financial and governance benefits.EXPI
Proxy filing22 Apr 2026 - Proxy solicitor engaged for 2026 Annual Meeting to support redomestication vote.EXPI
Proxy filing20 Apr 2026 - Shareholders to vote on Texas redomestication, governance, and compensation changes.EXPI
Proxy Filing9 Mar 2026 - Board recommends approval of director elections, auditor, executive pay, and Texas redomestication.EXPI
Proxy Filing25 Feb 2026 - 2025 revenue rose 4% to $4.8B, with 67% international growth and strong agent productivity.EXPI
Q4 202524 Feb 2026 - Q2 2024 revenue up 5% to $1.3B, adjusted EBITDA up 22%, and $56M returned to shareholders.EXPI
Q2 20242 Feb 2026